Intraovarian Activins Are Required for Female Fertility

Total Page:16

File Type:pdf, Size:1020Kb

Intraovarian Activins Are Required for Female Fertility 0888-8809/07/$15.00/0 Molecular Endocrinology 21(10):2458–2471 Printed in U.S.A. Copyright © 2007 by The Endocrine Society doi: 10.1210/me.2007-0146 Intraovarian Activins Are Required for Female Fertility Stephanie A. Pangas,* Carolina J. Jorgez,* Mai Tran, Julio Agno, Xiaohui Li, Chester W. Brown, T. Rajendra Kumar, and Martin M. Matzuk Departments of Pathology (S.A.P., M.T., J.A., X.L., M.M.M.), Molecular and Human Genetics (C.W.B.), Molecular and Cellular Biology (M.M.M.), and Program in Developmental Biology (C.J.J., M.M.M.), Baylor College of Medicine, Houston, Texas 77030; and Department of Molecular and Integrative Physiology (T.R.K.), The University of Kansas Medical Center, Kansas 66160 Downloaded from https://academic.oup.com/mend/article/21/10/2458/2738443 by guest on 30 September 2021 Activins have diverse roles in multiple physiologi- are subfertile, ␤B/␤A double mutant females are cal processes including reproduction. Mutations infertile. Strikingly, the activin ␤A and ␤B/␤A-defi- and loss of heterozygosity at the human activin cient ovaries contain increased numbers of func- receptor ACVR1B and ACVR2 loci are observed in tional corpora lutea but do not develop ovarian pituitary, pancreatic, and colorectal cancers. Func- tumors. Microarray analysis of isolated granulosa tional studies support intraovarian roles for ac- cells identifies significant changes in expression tivins, although clarifying the in vivo roles has re- for a number of genes with known reproductive mained elusive due to the perinatal death of activin roles, including Kitl, Taf4b, and Ghr, as well as loss ␤A knockout mice. To study the roles of activins in of expression of the proto-oncogene, Myc. Thus, in ovarian growth, differentiation, and cancer, a tis- contrast to the known tumor suppressor role of sue-specific knockout system was designed to ab- activins in some tissues, our data indicate that activin late ovarian production of activins. Mice lacking ␤A and ␤B function redundantly in a growth stimu- ovarian activin ␤A were intercrossed to Inhbb ho- latory pathway in the mammalian ovary (Molecular mozygous null mice to produce double activin Endocrinology 21: 2458–2471, 2007) knockouts. Whereas ovarian ␤A knockout females CTIVINS, HOMODIMERS OR heterodimers of ␤Aor growth of both human breast cancer cells (7) and prostate A␤B-subunits, were identified for their roles in posi- cancer cells (8). Mutations in ACVR1B have been observed tively regulating pituitary FSH synthesis and secretion in human pituitary tumors (9) and pancreatic cancers (10). (1–3). The ␤-subunits also dimerize with the inhibin Likewise, ACVR2 mutations and loss of heterozygosity ␣-subunit to produce inhibins [inhibin A (␣:␤A) and in- have been seen in pancreatic (11), colorectal (12), and pros- hibin B (␣:␤B)] that negatively regulate FSH. The ␤A- and tate cancers (13). These studies suggest that the activin ␤B-subunits, encoded by the Inhba and Inhbb genes, signaling pathway functions as a tumor suppressor path- respectively, are produced in multiple tissues during em- way in some tissues to block cell growth and stimulate bryonic and postnatal development and have diverse differentiation. physiological effects. Mice lacking activin ␤A (homozy- Inhba and Inhbb transcripts are prominently expressed gous Inhba null) die at birth secondary to craniofacial by granulosa cells of large preantral and antral follicles (14). defects, whereas homozygous Inhbb null mice are viable In vitro studies have identified multiple intraovarian roles for but exhibit eyelid closure and nursing defects (4–6). activins in granulosa cells including proliferation, potentia- Several studies indicate that activin signaling compo- tion of FSH action, and modulation of steroidogenesis (re- nents, including the receptors ACVR1B (also known as viewed in Refs. 15 and 16). To study the in vivo roles of activins, we produced an ovarian Inhba conditional knock- ALK4) and ACVR2 (also known as ACTR2B), are critical for out (␤A cKO). We also generated the ␤A cKO in the Inhbb growth inhibition. For example, activins inhibit in vitro null background mice to produce mice lacking all ovarian First Published Online July 3, 2007 activins (double mutant mice; herein designated as ␤B/␤A * S.A.P. and C.J.J. contributed equally to this work. dKO). In contrast to extragonadal roles of these proteins as Abbreviations: BMP, Bone morphogenetic protein; cKO, tumor suppressors, activins play redundant roles to block conditional knockout; CL(s), corpus luteum/corpora lutea; Ctgf, connective tissue growth factor; CV, coefficient of vari- terminal differentiation of granulosa cells, leading to dos- ation; dKO, double mutant mice; Gapd, glyceraldehyde age-dependent fertility defects. 3-phosphate dehydrogenase; Ghr, GH receptor; hCG, human chorionic gonadotropin; 20␣-HSD, 20␣-hydroxysteroid de- hydrogenase; HSD, honestly significant difference; Lhcgr,LH receptor; Mmp2, matrix metalloproteinase 2; PMSG, preg- RESULTS nant mare serum gonadotropin; PRL, prolactin; qPCR, quan- titative PCR. Generation of Ovarian Activin ␤A Knockout Mice Molecular Endocrinology is published monthly by The Endocrine Society (http://www.endo-society.org), the tm3Zuk foremost professional society serving the endocrine A floxed Inhba allele was generated (Inhba ; community. herein called ␤Aflox) for subsequent tissue-specific de- 2458 Pangas et al.•In Vivo Roles of Activins in the Ovary Mol Endocrinol, October 2007, 21(10):2458–2471 2459 letion of the Inhba gene in vivo (Fig. 1A). Exon 2 was ␤BϪ/Ϫ; ␤Aflox/Ϫ, and ␤BϪ/Ϫ; ␤Aflox/Ϫ;Amhr2cre/ϩ fe- floxed because it encodes the entire mature domain of males. Neither ␤Aϩ/Ϫ nor ␤Bϩ/Ϫ heterozygous mice the protein and a conditional exon 2 deletion would had fertility defects (5, 17). Double mutant females mimic the original null allele (Inhbatm1Zuk) (17). ␤Aflox/ϩ with only one remaining ␤A-subunit allele (␤BϪ/Ϫ; mice were intercrossed to produce ␤Aflox/flox homozy- ␤Aϩ/Ϫ or ␤BϪ/Ϫ;␤Aflox/Ϫ) had severe fertility defects gous mice, which were viable and fertile and obtained (Table 1), indicating that activin dosage plays an im- at the expected Mendelian frequency. To verify the portant role in ovarian function. Of the 16 mice that presence of loxP sites and their ability to recombine in were studied over 6 months, three of five ␤BϪ/Ϫ; vivo, we crossed the ␤Aflox mice to EIIa-cre transgenic ␤Aflox/Ϫ, and three of 11 ␤BϪ/Ϫ;␤Aϩ/Ϫ female mice mice, which express cre recombinase in multiple tis- were infertile. In the mutant lines containing a single ␤ sues, including germ cells (18). Southern blot analysis -subunit allele, the average number of litters per Downloaded from https://academic.oup.com/mend/article/21/10/2458/2738443 by guest on 30 September 2021 using a 5Ј probe demonstrated the presence of the month was significantly reduced (89–91%), and the various Inhba alleles, including the recombined de- number of pups per litter was 87–90% lower than the leted (␤A⌬) (data not shown). Because ␤Aflox/Ϫ;EIIa-cre controls (Table 1). Finally, female mice lacking all in- newborn mice demonstrate the neonatal lethality seen traovarian activin ␤A and ␤B alleles (␤BϪ/Ϫ;␤Aflox/Ϫ; in the Inhba homozygous null mice (data not shown), Amhr2cre/ϩ) were infertile (Table 1). Thus, although recombination likely produced a null allele. activin A appears to be functionally dominant [be- Anti-Mu¨ llerian hormone receptor-cre (Amhr2cre/ϩ) cause activin A deficiency results in subfertility vs. knock-in mice were used to generate recombination of normal fertility for activin ␤B deficiency (5)], dosage of ␤Aflox in ovarian granulosa cells (19–21). ␤Aϩ/Ϫ; the activin ␤A and ␤B alleles is important for normal Amhr2cre/ϩ mice were mated to ␤Aflox/flox mice and all fertility. four genotypes were recovered at the expected Men- To assess whether ovulation defects were present in delian frequency. Recombination efficiency of the the activin-deficient females, 3-wk-old females were ␤Aflox locus was determined by Southern blot analysis superovulated, mated and oocytes collected from ovi- of granulosa cells derived from cre-negative ␤Aflox/Ϫ ducts. Four groups of mice were analyzed: wild-type, (control) mice and ␤Aflox/Ϫ;Amhr2cre/ϩ (experimental) ␤Aflox/Ϫ, ␤Aflox/Ϫ;Amhr2cre/ϩ, ␤BϪ/Ϫ;␤Aflox/Ϫ, and mice (Fig. 1B). Recombination of the floxed allele in ␤BϪ/Ϫ;␤Aflox/;Amhr2cre/ϩ. There were no significant granulosa cells from female littermates varied from differences in the number of oocytes released after 60% to 99% (Fig. 1B). Variation in recombination and ovulation, except in mice deficient for all ␤-subunits expression differences are likely the result of mo- (Table 2). Two of four female mice deficient for all sacism in recombination, as has been seen in other activin alleles produced no oocytes. conditional knockout mice using Amhr2-cre mice (21, 22). Loss of the ␤A transcript was confirmed by North- Enhanced Corpus Luteum (CL) Formation in ern blot analysis (Fig. 1C), and no compensatory up- Activin-Deficient Ovaries regulation of the activin ␤B-subunit was found in ␤Aflox/Ϫ;Amhr2cre/ϩ ovaries (Fig. 1D). Because the To determine the causes of subfertility/infertility in the ␤-subunit is also required for formation of inhibin, we activin-deficient mice, ovaries were analyzed at 3 and measured serum inhibin levels in the ␤Aflox/Ϫ; 8 months of age. At 3 months of age, there were no Amhr2cre/ϩmice. The average serum inhibin A level in gross differences in appearance or size of the ovaries the ␤A-deficient mice is significantly reduced from the between ␤Aflox/Ϫ;Amhr2cre/ϩ and control mice control values, and six of nine females had undetect- (␤Aflox/Ϫ) (data not shown). The only visible histological able levels. Loss of dimeric inhibin A was not due to difference at 3 months of age was the presence of reductions in inhibin ␣-subunit mRNA expression be- ovarian follicles containing more than one oocyte cause ovaries and granulosa cells of mutant mice [50% occurrence in the experimental mice vs.
Recommended publications
  • Bone Morphogenetic Protein Antagonist Gremlin-1 Regulates Colon Cancer Progression
    Biol. Chem. 2015; 396(2): 163–183 George S. Karagiannis, Natasha Musrap, Punit Saraon, Ann Treacy, David F. Schaeffer, Richard Kirsch, Robert H. Riddell and Eleftherios P. Diamandis* Bone morphogenetic protein antagonist gremlin-1 regulates colon cancer progression Abstract: Bone morphogenetic proteins (BMP) are phylo- E-cadherin-upregulation of N-cadherin) and overexpres- genetically conserved signaling molecules of the trans- sion of Snail. Collectively, our data support that GREM1 forming growth factor-beta (TGF-beta) superfamily of promotes the loss of cancer cell differentiation at the can- proteins, involved in developmental and (patho)physi- cer invasion front, a mechanism that may facilitate tumor ological processes, including cancer. BMP signaling has progression. been regarded as tumor-suppressive in colorectal cancer (CRC) by reducing cancer cell proliferation and invasion, Keywords: angiogenesis; bone morphogenetic protein; and by impairing epithelial-to-mesenchymal transition cancer-associated fibroblasts; colorectal cancer; epithe- (EMT). Here, we mined existing proteomic repositories lial-to-mesenchymal transition; gremlin-1; stroma; tumor to explore the expression of BMPs in CRC. We found that microenvironment. the BMP antagonist gremlin-1 (GREM1) is secreted from heterotypic tumor-host cell interactions. We then sought DOI 10.1515/hsz-2014-0221 to investigate whether GREM1 is contextually and mecha- Received June 26, 2014; accepted August 1, 2014; previously nistically associated with EMT in CRC. Using immunohis- published
    [Show full text]
  • An Autocrine Activinb Mechanism Drives TGF /Activin Signaling In
    An autocrine ActivinB mechanism drives TGF β/Activin signaling in Group 3 medulloblastoma Morgane Morabito, Magalie Larcher, Florence M G Cavalli, Chloé Foray, Antoine Forget, Liliana Mirabal-ortega, Mamy Andrianteranagna, Sabine Druillennec, Alexandra Garancher, Julien Masliah-planchon, et al. To cite this version: Morgane Morabito, Magalie Larcher, Florence M G Cavalli, Chloé Foray, Antoine Forget, et al.. An autocrine ActivinB mechanism drives TGF β/Activin signaling in Group 3 medulloblastoma. EMBO Molecular Medicine, Wiley Open Access, 2019, 6, pp.e9830. 10.15252/emmm.201809830. hal-02347105 HAL Id: hal-02347105 https://hal.archives-ouvertes.fr/hal-02347105 Submitted on 5 Nov 2019 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Article An autocrine ActivinB mechanism drives TGFb/ Activin signaling in Group 3 medulloblastoma Morgane Morabito1,2,3,4,5, Magalie Larcher1,2,3,4,5, Florence MG Cavalli6,7, Chloé Foray1,2,3,4,5, Antoine Forget1,2,3,4,5, Liliana Mirabal-Ortega1,2,3,4,5, Mamy Andrianteranagna5,8,9,10,11,12,13, Sabine Druillennec1,2,3,4,5,
    [Show full text]
  • Gremlin1 Preferentially Binds to Bone Morphogenetic Protein-2 (BMP-2) and BMP-4 Over BMP-7
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Queen's University Research Portal Gremlin1 preferentially binds to Bone Morphogenetic Protein-2 (BMP-2) and BMP-4 over BMP-7 Church, R. H., Krishnakumar, A., Urbanek, A., Geschwinder, S., Meneely, J., Bianchi, A., ... Brazil, D. P. (2015). Gremlin1 preferentially binds to Bone Morphogenetic Protein-2 (BMP-2) and BMP-4 over BMP-7. Biochemical Journal, 466(1), 55-68. DOI: 10.1042/BJ20140771 Published in: Biochemical Journal Document Version: Peer reviewed version Queen's University Belfast - Research Portal: Link to publication record in Queen's University Belfast Research Portal Publisher rights The final version of record is available at http://www.biochemj.org/bj/imps/abs/BJ20140771.htm General rights Copyright for the publications made accessible via the Queen's University Belfast Research Portal is retained by the author(s) and / or other copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated with these rights. Take down policy The Research Portal is Queen's institutional repository that provides access to Queen's research output. Every effort has been made to ensure that content in the Research Portal does not infringe any person's rights, or applicable UK laws. If you discover content in the Research Portal that you believe breaches copyright or violates any law, please contact [email protected]. Download date:15. Feb. 2017 Differential Gremlin1 binding to Bone Morphogenetic Proteins Gremlin1 preferentially binds to Bone Morphogenetic Protein-2 (BMP-2) and BMP-4 over BMP-7 Rachel H.
    [Show full text]
  • Tumor Promoting Effect of BMP Signaling in Endometrial Cancer
    International Journal of Molecular Sciences Article Tumor Promoting Effect of BMP Signaling in Endometrial Cancer Tomohiko Fukuda 1,* , Risa Fukuda 1, Kohei Miyazono 1,2,† and Carl-Henrik Heldin 1,*,† 1 Science for Life Laboratory, Department of Medical Biochemistry and Microbiology, Box 582, Uppsala University, SE-751 23 Uppsala, Sweden; [email protected] (R.F.); [email protected] (K.M.) 2 Department of Molecular Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan * Correspondence: [email protected] (T.F.); [email protected] (C.-H.H.); Tel.: +46-18-4714738 (T.F.); +46-18-4714738 (C.-H.H.) † These authors contributed equally to this work. Abstract: The effects of bone morphogenetic proteins (BMPs), members of the transforming growth factor-β (TGF-β) family, in endometrial cancer (EC) have yet to be determined. In this study, we analyzed the TCGA and MSK-IMPACT datasets and investigated the effects of BMP2 and of TWSG1, a BMP antagonist, on Ishikawa EC cells. Frequent ACVR1 mutations and high mRNA expressions of BMP ligands and receptors were observed in EC patients of the TCGA and MSK-IMPACT datasets. Ishikawa cells secreted higher amounts of BMP2 compared with ovarian cancer cell lines. Exogenous BMP2 stimulation enhanced EC cell sphere formation via c-KIT induction. BMP2 also induced EMT of EC cells, and promoted migration by induction of SLUG. The BMP receptor kinase inhibitor LDN193189 augmented the growth inhibitory effects of carboplatin. Analyses of mRNAs of several BMP antagonists revealed that TWSG1 mRNA was abundantly expressed in Ishikawa cells.
    [Show full text]
  • A Collagen-Remodeling Gene Signature Regulated by TGF-B Signaling Is Associated with Metastasis and Poor Survival in Serous Ovarian Cancer
    Published OnlineFirst November 11, 2013; DOI: 10.1158/1078-0432.CCR-13-1256 Clinical Cancer Imaging, Diagnosis, Prognosis Research A Collagen-Remodeling Gene Signature Regulated by TGF-b Signaling Is Associated with Metastasis and Poor Survival in Serous Ovarian Cancer Dong-Joo Cheon1, Yunguang Tong2, Myung-Shin Sim7, Judy Dering6, Dror Berel3, Xiaojiang Cui1, Jenny Lester1, Jessica A. Beach1,5, Mourad Tighiouart3, Ann E. Walts4, Beth Y. Karlan1,6, and Sandra Orsulic1,6 Abstract Purpose: To elucidate molecular pathways contributing to metastatic cancer progression and poor clinical outcome in serous ovarian cancer. Experimental Design: Poor survival signatures from three different serous ovarian cancer datasets were compared and a common set of genes was identified. The predictive value of this gene signature was validated in independent datasets. The expression of the signature genes was evaluated in primary, metastatic, and/or recurrent cancers using quantitative PCR and in situ hybridization. Alterations in gene expression by TGF-b1 and functional consequences of loss of COL11A1 were evaluated using pharmacologic and knockdown approaches, respectively. Results: We identified and validated a 10-gene signature (AEBP1, COL11A1, COL5A1, COL6A2, LOX, POSTN, SNAI2, THBS2, TIMP3, and VCAN) that is associated with poor overall survival (OS) in patients with high-grade serous ovarian cancer. The signature genes encode extracellular matrix proteins involved in collagen remodeling. Expression of the signature genes is regulated by TGF-b1 signaling and is enriched in metastases in comparison with primary ovarian tumors. We demonstrate that levels of COL11A1, one of the signature genes, continuously increase during ovarian cancer disease progression, with the highest expression in recurrent metastases.
    [Show full text]
  • The Novel Cer-Like Protein Caronte Mediates the Establishment of Embryonic Left±Right Asymmetry
    articles The novel Cer-like protein Caronte mediates the establishment of embryonic left±right asymmetry ConcepcioÂn RodrõÂguez Esteban*², Javier Capdevila*², Aris N. Economides³, Jaime Pascual§,AÂ ngel Ortiz§ & Juan Carlos IzpisuÂa Belmonte* * The Salk Institute for Biological Studies, Gene Expression Laboratory, 10010 North Torrey Pines Road, La Jolla, California 92037, USA ³ Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, New York 10591, USA § Department of Molecular Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA ² These authors contributed equally to this work ............................................................................................................................................................................................................................................................................ In the chick embryo, left±right asymmetric patterns of gene expression in the lateral plate mesoderm are initiated by signals located in and around Hensen's node. Here we show that Caronte (Car), a secreted protein encoded by a member of the Cerberus/ Dan gene family, mediates the Sonic hedgehog (Shh)-dependent induction of left-speci®c genes in the lateral plate mesoderm. Car is induced by Shh and repressed by ®broblast growth factor-8 (FGF-8). Car activates the expression of Nodal by antagonizing a repressive activity of bone morphogenic proteins (BMPs). Our results de®ne a complex network of antagonistic molecular interactions between Activin, FGF-8, Lefty-1, Nodal, BMPs and Car that cooperate to control left±right asymmetry in the chick embryo. Many of the cellular and molecular events involved in the establish- If the initial establishment of asymmetric gene expression in the ment of left±right asymmetry in vertebrates are now understood. LPM is essential for proper development, it is equally important to Following the discovery of the ®rst genes asymmetrically expressed ensure that asymmetry is maintained throughout embryogenesis.
    [Show full text]
  • A Meta-Analysis of the Inhibin Network Reveals Prognostic Value in Multiple Solid Tumors
    bioRxiv preprint doi: https://doi.org/10.1101/2020.06.25.171942; this version posted June 27, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 A meta-analysis of the inhibin network reveals prognostic value in multiple solid tumors Eduardo Listik1†, Ben Horst1,2†, Alex Seok Choi1, Nam. Y. Lee3, Balázs Győrffy4 and Karthikeyan Mythreye1 Affiliations: 1Department of Pathology, University of Alabama at Birmingham, Birmingham AL, USA, 35294. 2Department of Chemistry and Biochemistry, University of South Carolina, Columbia SC, USA, 29208. 3 Division of Pharmacology, Chemistry and Biochemistry, College of Medicine, University of Arizona, Tucson, AZ, 85721, USA. 4 TTK Cancer Biomarker Research Group, Institute of Enzymology, and Semmelweis University Department of Bioinformatics and 2nd Department of Pediatrics, Budapest, Hungary. Corresponding author: Karthikeyan Mythreye, Ph.D. Division of Molecular and Cellular Pathology, Department of Pathology, The University of Alabama at Birmingham. WTI 320B, 1824 Sixth Avenue South, Birmingham, AL, USA, 35294. Phone : +1 205.934.2746 E-mail : [email protected] †The authors contributed equally to this work. bioRxiv preprint doi: https://doi.org/10.1101/2020.06.25.171942; this version posted June 27, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
    [Show full text]
  • Table SI. Characteristics of 9 Patients Chosen from 60 Patients with Hepatocellular Carcinoma
    Table SI. Characteristics of 9 patients chosen from 60 patients with hepatocellular carcinoma. Characteristic No. of patients (%) Age, years <50 3 (33.3) ≥50 6 (66.7) Sex Female 4 (44.4) Male 5 (55.6) Albumin, g/l ≥35 8 (88.9) <35 1 (11.1) AFP, ng/ml ≤20 2 (22.2) >20 7 (77.8) Tumor diameter, cm ≤5 3 (33.3) >5 6 (66.7) Portal vein invasion Without 3 (33.3) With 6 (66.7) BCLC stage A 2 (22.2) B/C 7 (77.8) AFP, α-fetoprotein; BCLC, Barcelona Clinic Liver Cancer. Table SII. List of the gene symbol and relative expression of six significant clusters. Gene symbol SPOT Profile Day 0 Day 3 Day 7 Day 14 Day 21 ALCAM ID_10 16 0 -356.5 378.5 0.1 307.8 ANGPT2 ID_13 16 0 -45.7 197.2 96 60.2 CD80 ID_24 16 0 -177 362 -29 187 CTNNB1 ID_29 16 0 -58 294 83 49 BMP4 ID_37 16 0 -107 189 0 53 CCL28 ID_49 16 0 -307 856 491 347 CCR1 ID_50 16 0 -189 391 236 112 CCR4 ID_53 16 0 -101 361 89 240 CCR7 ID_56 16 0 -98 361 103 66 CLC ID_70 16 0 -147 274 0 188 CRIM1 ID_74 16 0 -642 229 -48 -112 CXCL14 ID_83 16 0 -434 1,154.00 778 376 CXCL16 ID_84 16 0 -128 800 477 180 DKK3 ID_97 16 0 -199 610 107 3 FGFBP1 ID_129 16 0 -224 484 -155 37 FGF20 ID_147 16 0 -113 264 -32 -4 WFIKKN1 ID_163 16 0 -195 544 262 41 GFRA1 ID_175 16 0 -536 443 29 280 GFRA4 ID_178 16 0 -211 208 -47 116 TNFSF18 ID_180 16 0 -14 246 89 68 GPC5 ID_187 16 0 -180 1,345.00 298 509 GH1 ID_194 16 0 -596 206 10 -9 CCHCR1 ID_198 16 0 -108 322 50 238 NRG1 ID_200 16 0 -81 378.5 170.5 187 ICAM1 ID_207 16 0 -136 98 -17 63 IFNB1 ID_213 16 0 -87 233 143 29 IGFBP3 ID_218 16 0 -1,311.00 609 -368 -178 IGFBP4 ID_219 16 0
    [Show full text]
  • The BMP Antagonists Follistatin and Gremlin in Normal and Early Osteoarthritic Cartilage: an Immunohistochemical Study G
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Osteoarthritis and Cartilage (2009) 17, 263e270 ª 2008 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved. doi:10.1016/j.joca.2008.06.022 International Cartilage Repair Society The BMP antagonists follistatin and gremlin in normal and early osteoarthritic cartilage: an immunohistochemical study G. Tardif Ph.D., J.-P. Pelletier M.D., C. Boileau Ph.D. and J. Martel-Pelletier Ph.D.* Osteoarthritis Research Unit, University of Montreal Hospital Centre, Notre-Dame Hospital, Montreal, Quebec, Canada Summary Objective: Bone morphogenic protein (BMP) activities are controlled in part by antagonists. In human osteoarthritic (OA) cartilage, the BMP antagonists follistatin and gremlin are increased but differentially regulated. Using the OA dog model, we determined if these BMP antagonists were produced at different stages during the disease process by comparing their in situ temporal and spatial distribution. Methods: Dogs were sacrificed at 4, 8, 10 and 12 weeks after surgery; normal dogs served as control. Cartilage was removed, differentiating fibrillated and non-fibrillated areas. Immunohistochemistry and morphometric analyses were performed for follistatin, gremlin, BMP-2/4 and IL-1b. Growth factor-induced gremlin expression was assessed in dog chondrocytes. Results: Follistatin and gremlin production were very low in normal cartilage. Gremlin was significantly up-regulated in both non-fibrillated and fibrillated areas at 4 weeks, and only slightly increased with disease progression. Follistatin showed a time-dependent increased level in the non-fibrillated areas with significance reached at 8e12 weeks; in the fibrillated areas significant high levels were seen as early as 4 weeks.
    [Show full text]
  • Folliculogenesis and Fertilization in the Domestic Dog: Application to Biomedical Research, Medicine, and Conservation
    FOLLICULOGENESIS AND FERTILIZATION IN THE DOMESTIC DOG: APPLICATION TO BIOMEDICAL RESEARCH, MEDICINE, AND CONSERVATION A Dissertation Presented to the Faculty of the Graduate School of Cornell University in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy By Jennifer Beth Nagashima August 2015 © Jennifer Beth Nagashima FOLLICULOGENESIS AND FERTILIZATION IN THE DOMESTIC DOG: APPLICATIONS TO BIOMEDICAL RESEARCH, MEDICINE, AND CONSERVATION Jennifer Beth Nagashima, Ph.D. Cornell University 2015 Understanding of reproductive biology in canids, including the domestic dog, is surprisingly limited. This includes the regulators of ovarian follicle development, and mechanisms of anestrus termination, fertilization and embryo development. In turn, this lack of understanding has limited our ability to develop assisted reproductive technologies (ART) for endangered canid conservation efforts. ART of interest include in vitro follicle culture for maternal genome rescue, estrus induction protocols, and in vitro fertilization (IVF). Here, we describe: 1) Studies evaluating the stage-specific requirements for follicle stimulating hormone (FSH), luteinizing hormone (LH), and activin on domestic dog follicle development in vitro. We demonstrate the beneficial effects of FSH and activin on growth, and activin on antrum expansion and oocyte health in short term culture. 2) Evaluation of serum collected during the anestrus to estrus transition revealing a significant increase in anti-Müllerian hormone (AMH) during proestrus, likely originating from increased numbers of antral follicles during this time. 3) The birth of the first live puppies from IVF embryos utilizing in vivo matured oocytes. Further, consistently high rates of embryo production are obtained using the described system, with no effect of progesterone supplementation to embryo culture media.
    [Show full text]
  • FOP) Can Be Rescued by the Drug Candidate Saracatinib
    Stem Cell Reviews and Reports https://doi.org/10.1007/s12015-020-10103-9 ActivinA Induced SMAD1/5 Signaling in an iPSC Derived EC Model of Fibrodysplasia Ossificans Progressiva (FOP) Can Be Rescued by the Drug Candidate Saracatinib Susanne Hildebrandt1,2,3 & Branka Kampfrath1 & Kristin Fischer3,4 & Laura Hildebrand2,3 & Julia Haupt1 & Harald Stachelscheid3,4 & Petra Knaus 1,2 Accepted: 1 December 2020 # The Author(s) 2021 Abstract Balanced signal transduction is crucial in tissue patterning, particularly in the vasculature. Heterotopic ossification (HO) is tightly linked to vascularization with increased vessel number in hereditary forms of HO, such as Fibrodysplasia ossificans progressiva (FOP). FOP is caused by mutations in the BMP type I receptor ACVR1 leading to aberrant SMAD1/5 signaling in response to ActivinA. Whether observed vascular phenotype in human FOP lesions is connected to aberrant ActivinA signaling is unknown. Blocking of ActivinA prevents HO in FOP mice indicating a central role of the ligand in FOP. Here, we established a new FOP endothelial cell model generated from induced pluripotent stem cells (iECs) to study ActivinA signaling. FOP iECs recapitulate pathogenic ActivinA/SMAD1/5 signaling. Whole transcriptome analysis identified ActivinA mediated activation of the BMP/ NOTCH pathway exclusively in FOP iECs, which was rescued to WT transcriptional levels by the drug candidate Saracatinib. We propose that ActivinA causes transcriptional pre-patterning of the FOP endothelium, which might contribute to differential vascularity in FOP lesions compared to non-hereditary HO. Keywords FOP . BMP-receptor . Activin . iPSCs . Human endothelial cells . HO . Saracatinib Introduction pathological conditions such as cancer and chronic inflamma- tion [2].
    [Show full text]
  • Transcription Activation of FLRG and Follistatin by Activin A, Through Smad Proteins, Participates in a Negative Feedback Loop to Modulate Activin a Function
    Oncogene (2002) 21, 2227 ± 2235 ã 2002 Nature Publishing Group All rights reserved 0950 ± 9232/02 $25.00 www.nature.com/onc Transcription activation of FLRG and follistatin by activin A, through Smad proteins, participates in a negative feedback loop to modulate activin A function Laurent Bartholin1,3,Ve ronique Maguer-Satta1,3, Sandrine Hayette1,2, Sylvie Martel1, MyleÁ ne Gadoux2, Laura Corbo1, Jean-Pierre Magaud1,2 and Ruth Rimokh*,1 1INSERM U453, Centre LeÂon BeÂrard, 69373 Lyon, France; 2Laboratoire de CytogeÂneÂtique MoleÂculaire, HoÃpital Edouard Herriot, 69437 Lyon, France Signaling of TGFb family members such as activin is location (Hayette et al., 1998). FLRG is a secreted tightly regulated by soluble binding proteins. Follistatin glycoprotein which is highly homologous to follistatin, binds to activin A with high anity, and prevents activin a protein known to bind to activin, a member of the binding to its own receptors, thereby blocking its transforming growth factor b (TGFb) superfamily signaling. We previously identi®ed FLRG gene from a (Nakamura et al., 1990). Activin and follistatin B-cell leukemia carrying a t(11;19)(q13;p13) transloca- proteins were originally isolated from ovarian ¯uid as tion. We and others have already shown that FLRG, a result of their ability to stimulate and inhibit, which is highly homologous to follistatin, may be respectively, the secretion of follicle-stimulating hor- involved in the regulation of the activin function through mone from the pituitary gland (Phillips and de Kretser, its binding to activin. In this study, we found that, like 1998). Further studies have revealed that activin, a follistatin, FLRG protein inhibited activin A signaling as secreted protein produced by a variety of tissues, has demonstrated by the use of a transcriptional reporter important endocrine and paracrine roles.
    [Show full text]